Exact Mass: 250.1698
Exact Mass Matches: 250.1698
Found 82 metabolites which its exact mass value is equals to given mass value 250.1698,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rivastigmine
Rivastigmine is only found in individuals that have used or taken this drug. It is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimers type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.Rivastigmine is a carbamate derivative that is structurally related to physostigmine, but not to donepezil and tacrine. The precise mechanism of rivastigmine has not been fully determined, but it is suggested that rivastigmine binds reversibly with and inactivates chlolinesterase (eg. acetylcholinesterase, butyrylcholinesterase), preventing the hydrolysis of acetycholine, and thus leading to an increased concentration of acetylcholine at cholinergic synapses. The anticholinesterase activity of rivastigmine is relatively specific for brain acetylcholinesterase and butyrylcholinesterase compared with those in peripheral tissues. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2844 EAWAG_UCHEM_ID 2844; CONFIDENCE standard compound D020011 - Protective Agents D004791 - Enzyme Inhibitors
3-Hydroxylidocaine
3-Hydroxylidocaine is a metabolite of lidocaine. Lidocaine, Xylocaine, or lignocaine is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic or as a local anesthetic for minor surgery. (Wikipedia)
Naepaine
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
Lidocaine N-oxide
CONFIDENCE Transformation product with Reference Standard (Level 1); INTERNAL_ID 801 INTERNAL_ID 801; CONFIDENCE Transformation product with Reference Standard (Level 1) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3279 CONFIDENCE standard compound; INTERNAL_ID 2114
Acetamide, 2-(diethylamino)-N-(4-hydroxy-2,6-dimethylphenyl)-
Ditrimethylolpropane
CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3386; ORIGINAL_PRECURSOR_SCAN_NO 3383 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3354; ORIGINAL_PRECURSOR_SCAN_NO 3351 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3381; ORIGINAL_PRECURSOR_SCAN_NO 3380 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3363; ORIGINAL_PRECURSOR_SCAN_NO 3361 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3431; ORIGINAL_PRECURSOR_SCAN_NO 3427 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3382; ORIGINAL_PRECURSOR_SCAN_NO 3380 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7019; ORIGINAL_PRECURSOR_SCAN_NO 7016 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7038; ORIGINAL_PRECURSOR_SCAN_NO 7036 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7056; ORIGINAL_PRECURSOR_SCAN_NO 7054 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7076; ORIGINAL_PRECURSOR_SCAN_NO 7074 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7066; ORIGINAL_PRECURSOR_SCAN_NO 7063 CONFIDENCE standard compound; INTERNAL_ID 439; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7091; ORIGINAL_PRECURSOR_SCAN_NO 7088
RIVASTIGMINE
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D020011 - Protective Agents D004791 - Enzyme Inhibitors
tert-butyl N-[2-amino-2-(2-methylphenyl)ethyl]carbamate
4,4-(DIMETHYLCYCLOHEX-2-ENONE)-2-BORONIC ACID, PINACOL ESTER
N-METHYL-N-[3-(2-MORPHOLIN-4-YLETHOXY)BENZYL]AMINE
2-[4-(2-AMINO-ETHYL)-PHENOXY]-N,N-DIETHYL-ACETAMIDE
tert-butyl 2-cyano-7-azaspiro[3.5]nonane-7-carboxylate
5,5-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one
TERT-BUTYL 2-(AMINOMETHYL)-4-METHYLBENZYLCARBAMATE
4-{[(3-Dimethylamino-propyl)-methyl-amino]-methyl}-benzoic acid
2-Methyl-2-propanyl (3-amino-1-phenylpropyl)carbamate
2-(Diethylamino)-N-(4-hydroxy-2,6-dimethylphenyl)acetamide
2-[2-(2-Ethoxyethoxy)ethoxy]ethoxy-trimethylsilane
Silane, (alpha,alpha-dimethyl-p-isopropylbenzyloxy)trimethyl-
(1s,2s,9s,10r,14r)-6-oxo-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadecan-14-ium-14-olate
(1r,2s,9r,10s,11s)-11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadecan-6-one
5,10-diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-A.1',2'-D]pyrazine
{"Ingredient_id": "HBIN010946","Ingredient_name": "5,10-diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-A.1',2'-D]pyrazine","Alias": "NA","Ingredient_formula": "C14H22N2O2","Ingredient_Smile": "CCOC1=C2CCCN2C(=C3N1CCC3)OCC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40824","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
